Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,153
archived clinical trials in
Gout

Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
710
mi
from 98109
Santa Clara, CA
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
710
mi
from 98109
Santa Clara, CA
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
1026
mi
from 98109
Aurora, CO
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
1026
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
2424
mi
from 98109
Bridgeport, CT
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
2424
mi
from 98109
Bridgeport, CT
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
2322
mi
from 98109
Washington,
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
2529
mi
from 98109
Daytona Beach, FL
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
2529
mi
from 98109
Daytona Beach, FL
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
2181
mi
from 98109
Decatur, GA
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
2181
mi
from 98109
Decatur, GA
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
259
mi
from 98109
Coeur D Alene, ID
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
259
mi
from 98109
Coeur D Alene, ID
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
1867
mi
from 98109
Indianapolis, IN
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
1867
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
1939
mi
from 98109
Louisville, KY
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
1939
mi
from 98109
Louisville, KY
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
2091
mi
from 98109
Metairie, LA
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
2091
mi
from 98109
Metairie, LA
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
2328
mi
from 98109
Baltimore, MD
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
2485
mi
from 98109
Boston, MA
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
1450
mi
from 98109
Rochester, MN
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
1466
mi
from 98109
St. Joseph, MO
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
1466
mi
from 98109
St. Joseph, MO
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
490
mi
from 98109
Helena, MT
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
490
mi
from 98109
Helena, MT
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
1366
mi
from 98109
Omaha, NE
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
1366
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
2400
mi
from 98109
New York, NY
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
2187
mi
from 98109
Ashville, NC
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
2187
mi
from 98109
Ashville, NC
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
2020
mi
from 98109
Cleveland, OH
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
2020
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
147
mi
from 98109
Portland, OR
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
2373
mi
from 98109
Philadelphia, PA
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
2424
mi
from 98109
Charleston, SC
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
2424
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
2429
mi
from 98109
Norfolk, VA
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
2429
mi
from 98109
Norfolk, VA
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
2
mi
from 98109
Seattle, WA
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
710
mi
from 98109
Santa Clara, CA
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
710
mi
from 98109
Santa Clara, CA
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
1026
mi
from 98109
Aurora, CO
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
1026
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
2529
mi
from 98109
Daytona Beach, FL
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
2529
mi
from 98109
Daytona Beach, FL
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
2679
mi
from 98109
Honolulu, HI
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
2679
mi
from 98109
Honolulu, HI
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
1939
mi
from 98109
Louisville, KY
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
1939
mi
from 98109
Louisville, KY
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
1983
mi
from 98109
Jackson, MS
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
1983
mi
from 98109
Jackson, MS
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
2400
mi
from 98109
New York, NY
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
1010
mi
from 98109
Bismarck, ND
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
1010
mi
from 98109
Bismarck, ND
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
2020
mi
from 98109
Cleveland, OH
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
2020
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
1565
mi
from 98109
Tulsa, OK
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
1565
mi
from 98109
Tulsa, OK
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
2
mi
from 98109
Seattle, WA
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
Morehouse School of Medicine
2178
mi
from 98109
Atlanta, GA
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
Morehouse School of Medicine
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
Harvard University
2482
mi
from 98109
Cambridge, MA
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
Harvard University
2482
mi
from 98109
Cambridge, MA
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
Univ of Minnesota
1393
mi
from 98109
Minneapolis, MN
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
Univ of Minnesota
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
Mayo Clinic Rochester
1450
mi
from 98109
Rochester, MN
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
Mayo Clinic Rochester
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
Duke Univ Med Ctr
2341
mi
from 98109
Durham, NC
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
Duke Univ Med Ctr
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
University Hospitals of Cleveland
2024
mi
from 98109
Cleveland, OH
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
University Hospitals of Cleveland
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
Baylor College of Medicine
1890
mi
from 98109
Houston, TX
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
Baylor College of Medicine
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
University of Utah Health Sciences Center
702
mi
from 98109
Salt Lake City, UT
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
University of Utah Health Sciences Center
702
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
University of Vermont
2326
mi
from 98109
Burlington, VT
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
University of Vermont
2326
mi
from 98109
Burlington, VT
Click here to add this to my saved trials
Single and Multiple Dose Study in Japanese
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of Lesinurad in Healthy Male Japanese Subjects
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
710
mi
from 98109
Santa Clara, CA
Single and Multiple Dose Study in Japanese
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of Lesinurad in Healthy Male Japanese Subjects
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
710
mi
from 98109
Santa Clara, CA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
2079
mi
from 98109
Birmingham, AL
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
2079
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials